YOLFTbeta
19

Ugint Co Ltd

195990 · KQ · Industrials / Specialty Industrial Machinery

868.00KRW-12.00 (-1.36%)

Price History

Full chart

Market Stats

Previous Close880.00
Open900.00
Day Range860.00 – 900.00
52-Week Range1,052.00 – 8,940.00
Volume9.98K
Market Cap18.37B
P/E (TTM)0.00
Forward P/E0.00
Dividend Yield0.00%
Beta-0.22
50-Day Avg1,258.34
200-Day Avg2,405.10

About

RootK Co., Ltd. manufactures and sells machine tools and biotechnology products in South Korea and internationally. It offers tapping centers, spindle machines, machining and turning centers, and machining centers with long table. Additionally, It also offers bispecific antibody therapeutics for ophthalmic and oncology indications, including anti-VEGF/ANG2, anti-HER2/CD3, anti-GPC3/CD3, and anti-CLAUDIN18.2/CD3 antibody candidates targeting DME/Wet AMD, breast cancer, gastric cancer, and liver cancer.The company was formerly known as Abpro Bio Co., Ltd. and changed its name to RootK Co., Ltd. in June 2026. The company was founded in 1991 and is headquartered in Daegu, South Korea.

Company Details

  • SectorIndustrials
  • IndustrySpecialty Industrial Machinery
  • CEOMr. Lee Jae-yong
  • Employees38
  • HeadquartersTechno sunhwan-ro 1-gil, Daegu, South Korea, 43022, Korea
  • Websitehttps://www.abprobio.co.kr

Leadership

  • Mr. Lee Jae-yongCEO & Executive Director · b. 1962
  • Mr. Ho-jun JangExecutive Director · b. 1970
  • Mr. Hyung suk KwonExecutive Director · b. 1967
  • Mr. HoJeong JoExecutive Director · b. 1974

Financials

Income Statement

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Revenue86.00B77.10B49.52B45.94B58.86B31.93B49.28B32.91B22.11B25.38B31.66B31.92B
Growth (%)--10.35%-35.77%-7.22%+28.11%-45.75%+54.34%-33.21%-32.82%+14.76%+24.78%+0.82%
Cost of Revenue59.90B54.75B35.71B43.91B50.00B44.61B43.79B28.99B20.49B24.11B31.05B28.41B
Gross Profit26.10B22.35B13.81B2.03B8.86B-12.68B5.49B3.93B1.62B1.27B616.30M3.51B
Gross Margin30.35%28.99%27.89%4.42%15.06%-39.71%11.15%11.93%7.32%5.00%1.95%11.00%
Operating Expense8.95B9.64B12.86B14.25B13.92B21.09B32.21B8.89B2.12B11.16B37.57B12.79B
Operating Income17.15B12.71B947.39M-12.22B-5.06B-33.77B-26.71B-4.96B-499.58M-9.89B-36.95B-9.28B
Operating Margin19.94%16.48%1.91%-26.60%-8.60%-105.78%-54.21%-15.07%-2.26%-38.99%-116.71%-29.06%
EBITDA---------2.15B-21.45B-12.48B-46.27B
EBITDA Margin---------9.73%-84.52%-39.42%-144.95%
Net Income14.75B15.02B17.33M-11.63B-11.06B-35.69B-58.97B-10.03B-8.14B-25.74B-15.63B-48.92B
Net Income Margin17.15%19.48%0.04%-25.30%-18.79%-111.79%-119.66%-30.47%-36.83%-101.44%-49.36%-153.24%
R&D1.32B1.50B1.54B1.37B1.21B1.98B1.29B562.30M879.91M573.04M448.27M436.61M
R&D as % of Total Revenue1.53%1.94%3.11%2.98%2.06%6.20%2.61%1.71%3.98%2.26%1.42%1.37%
Interest Expense000002.21B5.04B6.86B4.59B2.34B2.09B1.37B
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%6.91%10.22%20.84%20.76%9.22%6.60%4.29%

Balance Sheet

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Total Assets119.41B137.03B166.42B171.93B176.47B189.13B166.03B167.88B156.65B142.11B141.26B74.78B
Total Liabilities52.62B33.18B56.77B74.29B69.59B70.70B26.93B30.34B16.45B19.77B33.25B20.75B
Total Equity66.17B103.84B109.66B97.64B106.88B118.43B139.10B137.54B140.20B122.34B108.01B54.03B
Cash27.54B1.28B80240-18014.96B26.84B6.72M13.85M7.92M6.62M3.90B
Total Debt-25.14B11.78B17.25B9.94B13.38B11.20B-----
Net Debt-----26.01B----5.72B10.74B

Cash Flow

Currency: KRW2014-12-312015-12-312016-12-312017-12-312018-12-312019-12-312020-12-312021-12-312022-12-312023-12-312024-12-312025-12-31
Operating Cash Flow581.94M-324.61M-10.50B-34.22B2.47B2.67B2.76B-2.22B-12.46B-4.86B-5.75B-6.69B
Investing Cash Flow-29.76B-41.95B2.56B5.22B-7.61B-97.63B-405.95M8.35B-21.35B5.63B-6.79B-
Financing Cash Flow27.32B19.44B24.12B12.39B7.94B103.39B9.33B20.30B-3.37B1.18B8.57B-
Capital Expenditure26.32B2.57B1.92B2.53B1.30B2.79B270.79M542.24M132.25M2.24B17.13B2.30B
Free Cash Flow-----23.68M2.11B-6.01B-14.81B-7.10B-22.88B-8.99B
Dividends Paid2.71B3.44B3.23B---------
FCF to OCF-----0.89%76.33%270.57%118.86%146.04%397.81%134.39%

Earnings

Report DateMay 30, 2016Aug 29, 2016Nov 29, 2016Mar 2, 2017May 15, 2017Aug 14, 2017Nov 14, 2017Feb 28, 2018May 15, 2018Aug 13, 2018Feb 28, 2019May 15, 2019Aug 14, 2019Nov 14, 2019Feb 28, 2020Mar 31, 2020Jun 30, 2020Sep 30, 2020Dec 31, 2020Mar 31, 2021Jun 30, 2021Sep 30, 2021Dec 31, 2021Mar 31, 2022Jun 30, 2022Sep 30, 2022Dec 31, 2022Mar 31, 2023Jun 30, 2023Sep 30, 2023Dec 31, 2023Mar 31, 2024Jun 30, 2024Sep 30, 2024Dec 31, 2024Mar 31, 2025Jun 30, 2025Sep 30, 2025Dec 31, 2025Mar 31, 2026Jun 30, 2026
EPS Estimate-----------------------------------------
EPS Actual12.5126.00-8.34-26.13-50.154.15-39.72-71.555.28-33.19-92.22-9.60-98.65-50.36-100.22-349.91-1976.12-26.99-2752.98-147.33-485.12138.31-601.74-129.26-152.35-47.54-276.53-293.24-251.80-344.89-945.07-50.77-84.22595.91-1558.93-229.11-3117.18-14.48-75.97145.44-359.03
Surprise-----------------------------------------
TimingPre-marketPre-marketPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketAfter-hoursPre-marketPre-marketPre-marketPre-market--------------------------

Key Statistics & Ratios

Market Cap18.37B
Enterprise Value24.89B
Trailing P/E0.00
Forward P/E0.00
Price / Sales0.60
Price / Book0.36
Revenue (TTM)30.84B
Gross Profit (TTM)1.97B
EBITDA-8.16B
Profit Margin-16.41%
Operating Margin-45.59%
Return on Equity-8.87%
Return on Assets-7.47%
Shares Outstanding16.28M
Shares Float13.21M
Beta-0.22
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Dividends

20151×
933.33Dec 29, 2015

Stock Splits

  • Jul 30, 20261:2
  • Mar 12, 20261:10
  • Sep 11, 20171:5
  • Dec 14, 2016959692:319897
  • Nov 7, 20165:1
  • Dec 2, 20152:1